Human + AI

Creating the Investible Universe for Impact Investing

OmniVis

Source: www.omnivistech.com

Story

OmniVis is developing a handheld device that works with smartphones to detect cholera in water samples. With the help IoT technology, it can analyze and identify the bacteria within 30 minutes of collection. OmniVis technology uses a revolutionary sensing technique to quantify and analyze bio-molecular solutions directly at the source. The hardware device and consumable test kit attaches to a smartphone and reduces the detection process to 30 minutes, accurately and affordably.

She

CEO & Co-Founder

Katherine hails from San Francisco but moved to Purdue University for a PhD in mechanical engineering. In 2009 she studied abroad in Thailand, where she decided to focus on appropriate healthcare technologies for low resource settings. She used the principles from her PhD for the current OmniVis product(s).

Impact

10/90

90% of research money for biotechnology and genomics research only focuses on the health needs of 10% of the globe. This is known as the 10/90 Gap and Omnivis is looking to close that gap and bring solutions to the most vulnerable.

END 90% OF CHOLERA BY 2030

Omnivis is on the mission to end 90% of cholera by 2030.

UNITED NATIONS SDG 6

OmniVis is working towards United Nation’s Sustainability Development Goal #6 to provide universal and equitable access to safe and affordable drinking water by 2030 within a 30-minute round trip.